Pharma Journalist -

Proteome Sciences are pleased to announce the receipt of Good Clinical Laboratory Practice (GCLP) accreditation which will enable the Company to extend its proteomic services to the…
Read More...

MariMed client Kind Therapeutics USA LLC (Kind) has successfully passed the Maryland Cannabis Commission compliance inspection of its newly renovated facility designed and developed by…
Read More...

SMi reports: ReykHorland, Vice President, Business Development at TissUse GmbH to discuss “Applying Multi-Organ-on-a-Chip Technologies for Predictive Substance Testing" at SMi’s Drug…
Read More...

Now running for 10 years, SMi Group’s annual conference on Adaptive Designs in Clinical Trials returns to London in Spring 2018, gathering a senior audience of experts to discuss and…
Read More...

SMI REPORTS: Expert insight into tackling the scientific, regulatory and economic challenges to combat antimicrobial resistance. It is imperative for medical experts and drug…
Read More...

Orexo AB (publ.) announce that the European Medicines Agency (EMA) has granted a Marketing Authorization (MA) for Zubsolv (buprenorphine and naloxone), a novel rapidly-disintegrating…
Read More...

Novartis, the American Society for Clinical Pathology (ASCP) and the American Cancer Society (ACS) announced that they will work together to devise a common approach to improve access…
Read More...

Ionis Pharmaceuticals announced that it has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen) for which Ionis earned $5 million.…
Read More...

Cerecor Inc. and TRx Pharmaceuticals, LLC (TRx) announced that the companies have entered into a purchase agreement in which Cerecor will acquire TRx, including subsidiary Zylera…
Read More...

Samsung Bioepis Co., Ltd. announced the European Commission’s (EC) marketing authorization of ONTRUZANT, a biosimilar referencing Herceptin (trastuzumab), for the treatment of early…
Read More...